세계의 동물 신장질환 시장 보고서(2025년)

Veterinary renal disease encompasses a range of conditions that affect the kidneys of animals, resulting in impaired kidney function. This disruption affects the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues.

The main types of veterinary renal disease involve diagnosis and treatment. Diagnosis involves reaching a conclusion through medical evaluation, identifying specific conditions or diseases affecting an individual animal's health. The types of animals affected include canine, feline, bovine, equine, and others, with indications such as renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, among others. Treatment can be administered via injectable or oral routes and products are distributed through pharmacies, pet specialty stores, e-commerce platforms, and other channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary renal disease market research report is one of a series of new reports from The Business Research Company that provides veterinary renal disease market statistics, including veterinary renal disease industry global market size, regional shares, competitors with a veterinary renal disease market share, detailed veterinary renal disease market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary renal disease industry. This veterinary renal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary renal disease market size has grown strongly in recent years. It will grow from $15.5 billion in 2024 to $16.59 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growing disease awareness initiatives, the shift in consumer preferences towards natural and organic pet food, increasing pet ownership rates globally, regulatory changes in veterinary pharmaceuticals, and growing awareness about pet health and nutrition.

The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the emergence of personalized veterinary medicine, expansion of telemedicine and remote monitoring in veterinary care, rise in veterinary clinical trials and research, adoption of blockchain technology for supply chain transparency in veterinary products, and integration of artificial intelligence and machine learning in veterinary diagnostics. Major trends in the forecast period include increasing demand for veterinary teleconsultations, the surge in customized pet nutrition plans, the growth of wearable health monitoring devices for pets, the expansion of veterinary telemedicine platforms, and the adoption of precision medicine in veterinary oncology.

The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Import taxes on dialysis solutions and renal-specific diets may increase the cost of managing chronic kidney diseases in companion animals. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Increased pet ownership is expected to drive growth in the veterinary renal disease market. This market focuses on conditions affecting animals' kidneys, leading to impaired kidney function and symptoms such as increased thirst, frequent urination, and weight loss. The rise in veterinary renal disease is attributed to longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Treatments for veterinary renal disease typically involve dietary management, medication, and fluid therapy to manage symptoms and improve quality of life. For example, Cooper Pet Care reported that the European Union, including Norway and Switzerland, is expected to have around 145 million pets by October 2022, up from approximately 140 million in 2021, with about 66 million dogs and 79 million cats. Therefore, the growth of pet ownership is fueling the veterinary renal disease market.

Key players in this market are focused on advancing treatment and diagnosis technologies, such as novel diagnostic tests capable of detecting kidney injury even before clinical signs appear. These tests aim to identify subtle changes in renal function or structure, enabling early intervention to prevent advanced renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc. introduced the IDEXX Cystatin B Test, the first veterinary diagnostic test for detecting kidney injury in cats and dogs. This test helps veterinarians identify kidney injury early, leading to improved patient outcomes. It will be integrated into test panels assessing renal health during an estimated two million patient visits annually.

In July 2022, Dechra Pharmaceuticals plc acquired Piedmont Animal Health LLC for $210 million, enhancing its product development capabilities and offering innovative solutions for veterinarians and pet owners in areas of unmet medical needs, including veterinary renal disease. Piedmont Animal Health LLC is known for providing medicines for this specific condition.

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestle Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Sante Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

North America was the largest region in the veterinary renal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the veterinary renal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Renal Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary renal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary renal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary renal disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Treatment
• 2) By Animal Type: Canine; Feline; Bovine; Equine; Other Animal Types
• 3) By Indication: Renal Failure; Chronic Kidney Disease (CKD); Renal Cystitis; Kidney Stones; Nephritis; Other Indications
• 4) By Route of Administration: Injectable; Oral
• 5) By Distribution Channel: Pharmacies; Pet Specialty Stores; E-commerce; Other Distribution Channels
• Subsegments:
• 1) By Diagnosis: Blood Tests; Urine Tests; Imaging; Biopsy
• 2) By Treatment: Medications; Dialysis; Kidney Transplantation; Fluid Therapy
• Companies Mentioned: Bayer HealthCare Animal Health Inc.; Nestle Purina PetCare Company; Zoetis Inc.; Boehringer Ingelheim; Covetrus Inc.; Elanco Animal Health Incorporated; Hill's Pet Nutrition Inc.; IDEXX Laboratories Inc.; Ceva Sante Animale S.A.; Dechra Pharmaceuticals PLC; Neogen Corporation; Vetoquinol S.A.; Norbrook Laboratories Limited; Nutramax Laboratories Veterinary Sciences Inc.; Animalcare Group plc; Antech Diagnostics Inc.; Kindred Biosciences Inc.; Vedco Inc.; MSD Animal Health; Clinical Renal Associates; Veterinary Transplant Services Inc.; Kibow Biotech Inc.; Northwest Renal Clinic
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Renal Disease Market Characteristics

3. Veterinary Renal Disease Market Trends And Strategies

4. Veterinary Renal Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Veterinary Renal Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Renal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Renal Disease Market Growth Rate Analysis
• 5.4. Global Veterinary Renal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Renal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Renal Disease Total Addressable Market (TAM)

6. Veterinary Renal Disease Market Segmentation

• 6.1. Global Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• 6.2. Global Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine
• Feline
• Bovine
• Equine
• Other Animal Types
• 6.3. Global Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Renal Failure
• Chronic Kidney Disease (CKD)
• Renal Cystitis
• Kidney Stones
• Nephritis
• Other Indications
• 6.4. Global Veterinary Renal Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• 6.5. Global Veterinary Renal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies
• Pet Speciality Stores
• E-commerce
• Other Distribution Channels
• 6.6. Global Veterinary Renal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Urine Tests
• Imaging
• Biopsy
• 6.7. Global Veterinary Renal Disease Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Dialysis
• Kidney Transplantation
• Fluid Therapy

7. Veterinary Renal Disease Market Regional And Country Analysis

• 7.1. Global Veterinary Renal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Renal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Renal Disease Market

• 8.1. Asia-Pacific Veterinary Renal Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Renal Disease Market

• 9.1. China Veterinary Renal Disease Market Overview
• 9.2. China Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Renal Disease Market

• 10.1. India Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Renal Disease Market

• 11.1. Japan Veterinary Renal Disease Market Overview
• 11.2. Japan Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Renal Disease Market

• 12.1. Australia Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Renal Disease Market

• 13.1. Indonesia Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Renal Disease Market

• 14.1. South Korea Veterinary Renal Disease Market Overview
• 14.2. South Korea Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Renal Disease Market

• 15.1. Western Europe Veterinary Renal Disease Market Overview
• 15.2. Western Europe Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Renal Disease Market

• 16.1. UK Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Renal Disease Market

• 17.1. Germany Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Renal Disease Market

• 18.1. France Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Renal Disease Market

• 19.1. Italy Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Renal Disease Market

• 20.1. Spain Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Renal Disease Market

• 21.1. Eastern Europe Veterinary Renal Disease Market Overview
• 21.2. Eastern Europe Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Renal Disease Market

• 22.1. Russia Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Renal Disease Market

• 23.1. North America Veterinary Renal Disease Market Overview
• 23.2. North America Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Renal Disease Market

• 24.1. USA Veterinary Renal Disease Market Overview
• 24.2. USA Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Renal Disease Market

• 25.1. Canada Veterinary Renal Disease Market Overview
• 25.2. Canada Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Renal Disease Market

• 26.1. South America Veterinary Renal Disease Market Overview
• 26.2. South America Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Renal Disease Market

• 27.1. Brazil Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Renal Disease Market

• 28.1. Middle East Veterinary Renal Disease Market Overview
• 28.2. Middle East Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Renal Disease Market

• 29.1. Africa Veterinary Renal Disease Market Overview
• 29.2. Africa Veterinary Renal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Renal Disease Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Renal Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Renal Disease Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Renal Disease Market Competitive Landscape
• 30.2. Veterinary Renal Disease Market Company Profiles
  • 30.2.1. Bayer HealthCare Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Nestle Purina PetCare Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Covetrus Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Renal Disease Market Other Major And Innovative Companies

• 31.1. Elanco Animal Health Incorporated
• 31.2. Hill's Pet Nutrition Inc.
• 31.3. IDEXX Laboratories Inc.
• 31.4. Ceva Sante Animale S.A.
• 31.5. Dechra Pharmaceuticals PLC
• 31.6. Neogen Corporation
• 31.7. Vetoquinol S.A.
• 31.8. Norbrook Laboratories Limited
• 31.9. Nutramax Laboratories Veterinary Sciences Inc.
• 31.10. Animalcare Group plc
• 31.11. Antech Diagnostics Inc.
• 31.12. Kindred Biosciences Inc.
• 31.13. Vedco Inc.
• 31.14. MSD Animal Health
• 31.15. Clinical Renal Associates

32. Global Veterinary Renal Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Renal Disease Market

34. Recent Developments In The Veterinary Renal Disease Market

35. Veterinary Renal Disease Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Renal Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Renal Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Renal Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer